1. Home
  2. DAC vs TVTX Comparison

DAC vs TVTX Comparison

Compare DAC & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAC
  • TVTX
  • Stock Information
  • Founded
  • DAC 1972
  • TVTX 2008
  • Country
  • DAC Greece
  • TVTX United States
  • Employees
  • DAC N/A
  • TVTX N/A
  • Industry
  • DAC Marine Transportation
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DAC Consumer Discretionary
  • TVTX Health Care
  • Exchange
  • DAC Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • DAC 1.6B
  • TVTX 1.7B
  • IPO Year
  • DAC 2006
  • TVTX N/A
  • Fundamental
  • Price
  • DAC $85.14
  • TVTX $15.02
  • Analyst Decision
  • DAC Strong Buy
  • TVTX Strong Buy
  • Analyst Count
  • DAC 1
  • TVTX 14
  • Target Price
  • DAC $105.00
  • TVTX $33.31
  • AVG Volume (30 Days)
  • DAC 76.2K
  • TVTX 1.9M
  • Earning Date
  • DAC 05-13-2025
  • TVTX 05-01-2025
  • Dividend Yield
  • DAC 3.99%
  • TVTX N/A
  • EPS Growth
  • DAC N/A
  • TVTX N/A
  • EPS
  • DAC 24.48
  • TVTX N/A
  • Revenue
  • DAC $1,013,968,000.00
  • TVTX $273,533,000.00
  • Revenue This Year
  • DAC $2.95
  • TVTX $74.41
  • Revenue Next Year
  • DAC N/A
  • TVTX $48.90
  • P/E Ratio
  • DAC $3.48
  • TVTX N/A
  • Revenue Growth
  • DAC 3.10
  • TVTX 75.65
  • 52 Week Low
  • DAC $65.40
  • TVTX $6.79
  • 52 Week High
  • DAC $98.25
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • DAC 56.90
  • TVTX 35.45
  • Support Level
  • DAC $83.39
  • TVTX $16.37
  • Resistance Level
  • DAC $85.32
  • TVTX $15.48
  • Average True Range (ATR)
  • DAC 1.90
  • TVTX 1.00
  • MACD
  • DAC -0.34
  • TVTX -0.51
  • Stochastic Oscillator
  • DAC 35.33
  • TVTX 3.83

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: